+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ramucirumab"

Anti-VEGF Therapy for Cancer Market - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-VEGF Therapy for Cancer Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030 - Product Thumbnail Image

VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
From
Lung Cancer Drugs Market Report 2025 - Product Thumbnail Image

Lung Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Colorectal Cancer Drugs Market Report 2025 - Product Thumbnail Image

Colorectal Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Market Report 2025 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Metastatic Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Liver Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 287 Pages
  • Global
From
Biliary Tract Cancer (BTC)- Pipeline Insight, 2025 - Product Thumbnail Image

Biliary Tract Cancer (BTC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Metastatic Urothelial Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Urothelial Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
From
From
Synovial Sarcoma Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Synovial Sarcoma Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Carcinoid Tumor Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Carcinoid Tumor Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Biliary Tumors Pipeline Analysis Report 2025 - Product Thumbnail Image

Biliary Tumors Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
From
Loading Indicator

Ramucirumab is a monoclonal antibody used in the treatment of certain types of cancer. It is used in combination with other drugs to treat metastatic gastric cancer, metastatic non-small cell lung cancer, and metastatic colorectal cancer. It works by blocking the action of a protein called vascular endothelial growth factor (VEGF), which helps cancer cells grow and spread. Ramucirumab is approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Ramucirumab is a relatively new drug in the oncology market, but it has been gaining traction in recent years. It is used in combination with other drugs to treat a variety of cancers, and it has been shown to be effective in prolonging survival in some patients. It is also being studied in combination with other drugs for the treatment of other types of cancer. Some of the companies in the Ramucirumab market include Eli Lilly, AstraZeneca, Merck, and Pfizer. Show Less Read more